• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Evercore ISI Raises IBM Price Target Ahead of Q4 Earnings

user avatar

by Mohamed Farouk

2 hours ago


Evercore ISI has shown increased confidence in IBM's future performance by raising its price target ahead of the company's upcoming Q4 earnings report. This adjustment comes amid a backdrop of strong internal growth drivers that analysts believe will support the tech giant's trajectory, and the publication demonstrates positive momentum in the developments.

Analyst Raises Price Target for IBM

Analyst Amit Daryanani has increased the price target for IBM from $315 to $330, highlighting favorable conditions as the company approaches its earnings announcement. Despite the current short-term market volatility, Daryanani emphasizes that IBM is well-positioned for growth.

Key Factors Contributing to Optimism

Key factors contributing to this optimistic outlook include:

  • robust infrastructure momentum
  • recovery in consulting services
  • significant growth in AI-driven software solutions

These elements are expected to bolster IBM's performance, making it a compelling investment opportunity as the company prepares to report its financial results.

In a recent update, Citi analyst Atif Malik lowered his price target for Apple amid rising costs affecting profit margins, contrasting with Evercore ISI's optimistic outlook for IBM. For more details, see the full article here.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

YouTube Implements Creator Protections Alongside AI Tools

chest

YouTube has introduced likeness-detection technology to protect creators from unauthorized AI-generated content.

user avatarFilippo Romano

Moderna's Stock Soars After Positive Cancer Vaccine Data

chest

Moderna's shares surged by 7.19% to $46.09 after positive long-term data for their cancer vaccine was announced.

user avatarRajesh Kumar

Moderna and Merck Report Promising Results for Personalized Cancer Vaccine

chest

Moderna and Merck report significant five-year follow-up data showing a 49% reduction in melanoma recurrence risk with their personalized cancer vaccine.

user avatarEmily Carter

Goldman Sachs Addresses Market Volatility

chest

Goldman Sachs reassures investors that recent market fluctuations are a healthy correction rather than a crash.

user avatarTomas Novak

Veteran Trader Becomes Bullish on Bitcoin

chest

Veteran trader Tone Vays expresses a bullish outlook on Bitcoin, stating he will become super bullish if it closes above 43,500, indicating a potential breakout and increased market interest.

user avatarKaterina Papadopoulou

Analyst Predicts Potential Surge for Cardano (ADA)

chest

Crypto strategist Ali Martinez suggests that Cardano (ADA) is poised for a rally based on its descending triangle chart pattern.

user avatarMaya Lundqvist

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.